Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -107.92% is 11% above its 5-year average of -120.65%, around the middle of its 5-year range (-182.19%–-47.76%).
7.97% above its 12-month average of -117.27%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -93.63%.
OPERATING MARGIN
-107.92%
OPERATING MARGIN AVG TTM
-117.27%
OPERATING MARGIN AVG 3Y
-107.26%
OPERATING MARGIN AVG 5Y
-120.65%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+7.97%
CURRENT VS 3Y AVG
-0.62%
CURRENT VS 5Y AVG
+10.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Vivos Therapeutics, Inc.
Market Cap
$2.14M
Operating Margin
-107.92%
TTM Avg
-117.27%
3Y Avg
-107.26%
5Y Avg
-120.65%
Market Cap
$2.13M
Operating Margin
-869.34%
TTM Avg
-752.59%
3Y Avg
-4678.16%
5Y Avg
-3954.97%
Market Cap
$2.32M
Operating Margin
-102380.23%
TTM Avg
-77298.57%
3Y Avg
-57151.39%
5Y Avg
-38807.57%
Market Cap
$2.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Operating Margin
-778.16%
TTM Avg
-1508.06%
3Y Avg
-16162.65%
5Y Avg
-10775.10%
Market Cap
$2.38M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.38M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.88M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | $2.14M | -107.92% | -117.27% | -107.26% | -120.65% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | -869.34% | -752.59% | -4678.16% | -3954.97% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -102380.23% | -77298.57% | -57151.39% | -38807.57% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -778.16% | -1508.06% | -16162.65% | -10775.10% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | -324.34% | -372.21% | -997.85% | -1542.23% |
Gross Margin
59.7%
Operating Margin
-107.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -93.63% |
| 2026-03-31 | -128.67% |
| 2025-12-31 | -166.89% |
| 2025-09-30 | -69.79% |
| 2025-06-30 | -127.36% |
| 2025-03-31 | -129.91% |
| 2024-12-31 | -75.88% |
| 2024-09-30 | -68.52% |
| 2024-06-30 | -47.76% |
| 2024-03-31 | -110.70% |
| 2023-12-31 | -131.90% |
| 2023-09-30 | -110.27% |
| 2023-06-30 | -133.05% |
| 2023-03-31 | -129.76% |
| 2022-12-31 | -153.49% |
| 2022-09-30 | -127.34% |
| 2022-06-30 | -166.44% |
| 2022-03-31 | -182.19% |
| 2021-12-31 | -168.65% |
| 2021-09-30 | -121.05% |
| 2021-06-30 | -90.30% |
| 2021-03-31 | -98.78% |
| 2020-12-31 | -188.92% |
| 2020-09-30 | -55.21% |
| 2020-06-30 | -43.33% |
| 2020-03-31 | -80.02% |
| 2019-12-31 | -82.74% |
| 2019-09-30 | -92.16% |
| 2019-06-30 | -99.43% |
| 2019-03-31 | -99.43% |
